Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $15,864 - $25,568
-1,937 Reduced 1.78%
106,986 $1.01 Million
Q2 2022

Aug 15, 2022

SELL
$7.65 - $14.24 $10,235 - $19,053
-1,338 Reduced 1.21%
108,923 $1.11 Million
Q1 2022

May 16, 2022

BUY
$13.02 - $20.78 $615,676 - $982,623
47,287 Added 75.09%
110,261 $1.57 Million
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $1.22 Million - $1.61 Million
62,974 New
62,974 $1.3 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $149M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.